// App-Quantinova.ai

AB0505 (2018) : Early and sustained remission in sle can be achieved by using pulse methyl-prednisolone, hidroxychloroquine and low-medium dose-prednisone

Researchers

Presenter

  • B.R. Ruiz Estévez

Principal Investigators

  • G.R. Irastorza

  • E. Lázaro

  • I. Ruiz Arruza

  • P. Duffau

  • P. Blanco

Medical Centers

  • Systemic Autoimmune Diseases Unit, Cruces Hospital, Bilbao

  • Internal Medicine, Bordeaux Hospital, Bordeaux

  • Autoimmunity Diseases Unit, Cruces Hospital, Bilbao, Spain

  • Internal Medicine, Bordeaux University Hospital, Bordeaux, France,

Locations

  • Spain

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Methylprednisolone

  • Glucocorticoid

  • Prednisolone

  • Prednisone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved